FDMT

#2459

4D Molecular Therapeutics, Inc. Common Stock

9.6600

+1.58%

Сектор:

Базовая:

Валюта прибыли:

Дневной диапазон

Годовой диапазон

Дневное изменение

+1.58%

Месячное изменение

+12.98%

6-месячное изменение

-14.51%

Годовое изменение

-14.51%

Предыдущее закрытие

9.5100

Open

9.6600

Bid

Ask

Low

9.6600

High

9.6600

Объем

102

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Total assets 288.33 M353.49 M261.85 M339.89 M560.38 M Total liabilities 31.94 M34.38 M30.51 M32.06 M49.78 M Total equity 256.39 M319.11 M231.34 M307.83 M510.61 M Total liabilities & shareholders' equities 288.33 M353.49 M261.85 M339.89 M560.38 M Total debt ————— Net debt —————

Новости

4D Molecular Therapeutics, Inc. (FDMT) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:FDMT) 2026-01-19

RBC Capital подтверждает рейтинг Outperform для акций 4D Molecular с целью $32

RBC Capital reiterates Outperform rating on 4D Molecular stock at $32

Ашу Гупта продает акции 4D Molecular Therapeutics на $3,3 тыс.

Ashoo Gupta of 4D Molecular Therapeutics sells $3.3k in FDMT stock

4D Molecular Therapeutics: Jury Still Out On CF Gene Therapy After Dense Data Drop (NASDAQ:FDMT)

BlackBerry, FedEx, Nike And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Aimei Health Technology (NASDAQ:AFJK), Aura Biosciences (NASDAQ:AURA)

Avago and Oracle among market cap stock movers on Wednesday

4D Molecular Therapeutics, Inc. (FDMT) Discusses Interim Phase I Data From AEROW Trial in Cystic Fibrosis and Platform Potential Transcript

4D Molecular Therapeutics, Inc. (FDMT) Discusses Interim Phase I Data From AEROW Trial in Cystic Fibrosis and Platform Potential - Slideshow (NASDAQ:FDMT) 2025-12-17

4D Molecular Therapeutics, Inc. (FDMT) Presents at Jefferies London Healthcare Conference 2025 Transcript

Главный юрист 4D Molecular Therapeutics продает акции на $17 тыс.